Stock Track | Progyny Shares Plummet 5.35% Pre-Market Following BofA's Price Target Cut

Stock Track

May 09

Shares of Progyny (PGNY), a leading fertility benefits management company, plummeted 5.35% in pre-market trading on Friday. This significant drop comes as investors react to a recent analyst downgrade.

The catalyst for this decline appears to be a report from Bank of America Global Research, which cut its price objective for Progyny from $34 to $30. This reduction in the price target, announced early Friday morning before market open, has evidently shaken investor confidence in the stock.

Progyny, known for its innovative approach to fertility and family building benefits solutions, may face challenges in the near term according to this analyst perspective. While the full rationale behind BofA's decision wasn't immediately clear, such downgrades often reflect concerns about a company's growth prospects or valuation. Investors will likely be watching closely for any additional analyst comments or company updates that might provide more context for this adjusted outlook.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1146703015"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1146703015\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1146703015?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-09 21:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1146703015","market":"nz","top_or_hot":-1,"title":"Stock Track | Progyny Shares Plummet 5.35% Pre-Market Following BofA's Price Target Cut","media":"Stock Track","content":"<p>Shares of Progyny (PGNY), a leading fertility benefits management company, plummeted 5.35% in pre-market trading on Friday. This significant drop comes as investors react to a recent analyst downgrade.</p>\n\n<p>The catalyst for this decline appears to be a report from Bank of America Global Research, which cut its price objective for Progyny from $34 to $30. This reduction in the price target, announced early Friday morning before market open, has evidently shaken investor confidence in the stock.</p>\n\n<p>Progyny, known for its innovative approach to fertility and family building benefits solutions, may face challenges in the near term according to this analyst perspective. While the full rationale behind BofA's decision wasn't immediately clear, such downgrades often reflect concerns about a company's growth prospects or valuation. Investors will likely be watching closely for any additional analyst comments or company updates that might provide more context for this adjusted outlook.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Progyny Shares Plummet 5.35% Pre-Market Following BofA's Price Target Cut</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Progyny Shares Plummet 5.35% Pre-Market Following BofA's Price Target Cut\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-09 21:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Progyny (PGNY), a leading fertility benefits management company, plummeted 5.35% in pre-market trading on Friday. This significant drop comes as investors react to a recent analyst downgrade.</p>\n\n<p>The catalyst for this decline appears to be a report from Bank of America Global Research, which cut its price objective for Progyny from $34 to $30. This reduction in the price target, announced early Friday morning before market open, has evidently shaken investor confidence in the stock.</p>\n\n<p>Progyny, known for its innovative approach to fertility and family building benefits solutions, may face challenges in the near term according to this analyst perspective. While the full rationale behind BofA's decision wasn't immediately clear, such downgrades often reflect concerns about a company's growth prospects or valuation. Investors will likely be watching closely for any additional analyst comments or company updates that might provide more context for this adjusted outlook.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PGNY","symbol_name":"Progyny","start_time":0,"source_url":"","article_id":"1146703015","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1146703015","pubTimestamp":1746797796,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Progyny , a leading fertility benefits management company, plummeted 5.35% in pre-market trading on Friday. This significant drop comes as investors react to a recent analyst downgrade.The catalyst for this decline appears to be a report from Bank of America Global Research, which cut its price objective for Progyny from $34 to $30. This reduction in the price target, announced early Friday morning before market open, has evidently shaken investor confidence in the stock.Progyny, known","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"PGNY":"Progyny"},"translate_title":"美国银行下调目标价后，Progyny股价盘前暴跌5.35%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PGNY":1},"content_text":"Shares of Progyny (PGNY), a leading fertility benefits management company, plummeted 5.35% in pre-market trading on Friday. This significant drop comes as investors react to a recent analyst downgrade.\nThe catalyst for this decline appears to be a report from Bank of America Global Research, which cut its price objective for Progyny from $34 to $30. This reduction in the price target, announced early Friday morning before market open, has evidently shaken investor confidence in the stock.\nProgyny, known for its innovative approach to fertility and family building benefits solutions, may face challenges in the near term according to this analyst perspective. While the full rationale behind BofA's decision wasn't immediately clear, such downgrades often reflect concerns about a company's growth prospects or valuation. Investors will likely be watching closely for any additional analyst comments or company updates that might provide more context for this adjusted outlook.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}